Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -747.20% is 28% below its 5-year average of -586.02%, around the middle of its 5-year range (-2103.05%–0.00%).
8.46% below its 12-month average of -688.93%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1335.11%.
NET PROFIT MARGIN
-747.20%
NET PROFIT MARGIN AVG TTM
-688.93%
NET PROFIT MARGIN AVG 3Y
-537.03%
NET PROFIT MARGIN AVG 5Y
-586.02%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-8.46%
CURRENT VS 3Y AVG
-39.14%
CURRENT VS 5Y AVG
-27.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-287284.62%
vs the sector median at left
Nano-X Imaging Ltd.
Market Cap
$43.83M
Net Profit Margin
-747.20%
TTM Avg
-688.93%
3Y Avg
-537.03%
5Y Avg
-586.02%
Market Cap
$44.49M
Net Profit Margin
322.77%
TTM Avg
-172.32%
3Y Avg
-215.38%
5Y Avg
-270.73%
Market Cap
$43.06M
Net Profit Margin
-145.56%
TTM Avg
-153.73%
3Y Avg
-223.84%
5Y Avg
-240.41%
Market Cap
$44.73M
Net Profit Margin
-164.82%
TTM Avg
-1870.42%
3Y Avg
-1064.08%
5Y Avg
-709.38%
Market Cap
$44.71M
Net Profit Margin
32.60%
TTM Avg
-34.66%
3Y Avg
-64.33%
5Y Avg
-204.90%
Market Cap
$42.72M
Net Profit Margin
-84.93%
TTM Avg
-105.50%
3Y Avg
-125.06%
5Y Avg
-177.30%
Market Cap
$42.46M
Net Profit Margin
-13.86%
TTM Avg
-1.65%
3Y Avg
-39.69%
5Y Avg
-47.80%
Market Cap
$45.43M
Net Profit Margin
-375.77%
TTM Avg
-226.26%
3Y Avg
-308.90%
5Y Avg
-527.22%
Market Cap
$41.67M
Net Profit Margin
-4.42%
TTM Avg
-14.19%
3Y Avg
-49.13%
5Y Avg
-77.93%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $43.83M | -747.20% | -688.93% | -537.03% | -586.02% |
| DarioHealth Corp. (DRIO)vs › | $44.49M | 322.77% | -172.32% | -215.38% | -270.73% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.06M | -145.56% | -153.73% | -223.84% | -240.41% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.73M | -164.82% | -1870.42% | -1064.08% | -709.38% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 32.60% | -34.66% | -64.33% | -204.90% |
| CVRx, Inc. (CVRX)vs › | $42.72M | -84.93% | -105.50% | -125.06% | -177.30% |
| BioStem Technologies, Inc. (BSEM)vs › | $42.46M | -13.86% | -1.65% | -39.69% | -47.80% |
| Celularity Inc. (CELU)vs › | $45.43M | -375.77% | -226.26% | -308.90% | -527.22% |
| Precipio, Inc. (PRPO)vs › | $41.67M | -4.42% | -14.19% | -49.13% | -77.93% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.97M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-466.2%
Net Profit Margin
-747.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1335.11% |
| 2026-03-31 | -330.90% |
| 2025-12-31 | -897.36% |
| 2025-09-30 | -396.98% |
| 2025-06-30 | -484.28% |
| 2025-03-31 | -470.30% |
| 2024-12-31 | -468.70% |
| 2024-09-30 | -449.98% |
| 2024-06-30 | -502.96% |
| 2024-03-31 | -479.48% |
| 2023-12-31 | -427.53% |
| 2023-09-30 | -863.37% |
| 2023-06-30 | -672.50% |
| 2023-03-31 | -480.63% |
| 2022-12-31 | -2103.05% |
| 2022-09-30 | -784.50% |
| 2022-06-30 | -891.55% |
| 2022-03-31 | -1198.34% |
| 2021-12-31 | -1689.80% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
